Octagon Capital Advisors’s NewAmsterdam Pharma NAMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-408,000	Closed	-$9.65M	–	52
2024 Q1	$9.65M	Buy	+408,000	New	+$9.65M	1.16%	24